IMRX - Immuneering Corp

QQQ $ 473.14 $ -2.10 (-0.44 %)

DIA $ 417.33 $ 2.44 (0.59 %)

SPY $ 562.48 $ 0.83 (0.15 %)

TLT $ 101.29 $ 0.92 (0.92 %)

GLD $ 238.61 $ -0.02 (-0.01 %)

Previous Close

$ 2.87

Open

$ 2.10

Bid

$ 2.85 x 100

Ask

-- x --

Day's Range

$ 1.85 - $ 3.83

52 Week Range

$ 1.00 - $ 9.00

Volume

65,955,048

Average Volume

Market Cap

85.11M

Beta (5Y Monthly)

$ 0.76

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	03-01-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-04-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-10-2022	12-31-2021	10-K
12	11-09-2021	09-30-2021	10-Q
13	09-09-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-is-nanocap-immuneering-stock-trading-higher-on-friday

Why Is Nanocap Immuneering Stock Trading H...
09/13/2024 12:14:23

Immuneering reported promising initial response data from its Phase 2a trial for IMM-1-104 combined with modified gemcitabine/n...

Needham Reiterates Buy on Immuneering, Mai...
09/13/2024 09:42:43

Needham analyst Ami Fadia reiterates Immuneering (NASDAQ:IMRX) with a Buy and maintains $15 price target.

Immuneering Announces Initial Phase 2a Dat...
09/12/2024 20:09:47

Chardan Capital Maintains Buy on Immuneeri...
08/07/2024 11:57:01

Chardan Capital analyst Geulah Livshits maintains Immuneering (NASDAQ:IMRX) with a Buy and lowers the price target from $16 ...

5Needham Reiterates Buy on Immuneering, Ma...
08/07/2024 11:46:26

Needham analyst Ami Fadia reiterates Immuneering (NASDAQ:IMRX) with a Buy and maintains $15 price target.

Immuneering Q2 EPS $(0.47) Beats $(0.52) E...
08/06/2024 21:06:44

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.47) per share which beat the analyst consensus estimate of $(0.52) b...

Nasdaq Surges 1%; Meta Posts Upbeat Earnings
08/01/2024 14:15:23

why-carvana-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket

Why Carvana Shares Are Trading Higher By 1...
08/01/2024 12:32:25

Market-Moving News for August 1st
08/01/2024 12:21:36

META: 8% | Meta shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 gu...

Immuneering Granted FDA Fast Track Designa...
07/31/2024 20:59:40

- IMM-1-104 Fast Track designation now granted for the treatment of both first and second-line pancreatic ductal adenocarcinoma...

12-health-care-stocks-moving-in-tuesdays-after-market-session

12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 20:31:35

Needham Reiterates Buy on Immuneering, Mai...
05/08/2024 09:58:36

Needham analyst Ami Fadia reiterates Immuneering (NASDAQ:IMRX) with a Buy and maintains $15 price target.

Immuneering Q1 EPS $(0.49) Misses $(0.46) ...
05/07/2024 21:02:15

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46)...

Needham Reiterates Buy on Immuneering, Mai...
04/12/2024 10:33:08

Needham analyst Ami Fadia reiterates Immuneering (NASDAQ:IMRX) with a Buy and maintains $15 price target.

Immuneering Presented Preclinical Data At ...
04/09/2024 16:04:39

Globe Newswire- Preclinical data presented at AACR demonstrate that combining IMM-1-104 with chemotherapies used in the treatme...

Immuneering Announces First Patient Dosed ...
03/27/2024 12:08:00

- Deep Cyclic Inhibitor of the MAPK pathway demonstrated strong tumor growth inhibition in preclinical studies of RAF or RAS mu...

why-science-applications-international-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-mondays-mid-day-session

Why Science Applications International Sha...
03/18/2024 18:37:43

Shares of Science Applications International Corporation (NYSE: SAIC) fell sharply during Monday’s session after the company r...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
03/18/2024 17:31:33

cancer-treatment-focused-immuneering-faces-analyst-downgrades-who-cite-underwhelming-solid-tumor-trial-data

Cancer Treatment Focused Immuneering Faces...
03/15/2024 19:29:25

Immuneering shares dip as analysts express concern over IMM-1-104 trial results. Needham downgrades, citing efficacy issues des...

dow-falls-over-200-points-adobe-shares-plunge

Dow Falls Over 200 Points; Adobe Shares Pl...
03/15/2024 18:40:28

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 200 points on Friday. The Dow traded...